Activation of N-methyl-D-aspartate receptor attenuates acute responsiveness of δ-opioid receptors

Molecular Pharmacology

Volumn 51, Issue 4, 1997, Pages 583-587

  Cai, Ying Chun ^a   Ma, Lan ^b   Fan, Guo Huang ^a   Zhao, Jing ^b   Jiang, L I Zhen ^a   Pei, Gang ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHELERYTHRINE; COMPLEMENTARY DNA; CYCLIC AMP; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; KETAMINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NARCOTIC ANALGESIC AGENT; OPIATE AGONIST; PROTEIN KINASE C INHIBITOR; SIGMA OPIATE RECEPTOR;

ANALGESIA; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG TOLERANCE; EMBRYO; ENZYME INHIBITION; FETUS; GENE EXPRESSION; GLIOMA CELL; MOUSE; NERVE CELL CULTURE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0030955116     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.4.583     Document Type: Article

References (27)

1. Nestler, E. J. Under siege: the brain on opiates. Neuron 16:897-900 (1996).
2. Self, D. W., and E. J. Nestler. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18:463-495 (1995).
3. Cai, Y.-C., Y. Zhang, Y.-L. Wu, and G. Pei. δ opioid receptor in neuronal cells undergoes acute and homologous desensitization. Biochem. Biophys. Res. Commun. 219:342-347 (1996).
4. Arden, J. R., V. Segredo, Z. Wang, J. Lameh, and W. Sadee. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J. Neurochem. 65:1636-1645 (1995).
5. Mestek, A., J. H. Hurley, L. S. Bye, A. D. Campbell, Y. Chen, M. Tian, J. Liu, H. Schulman, and L. Yu. The human μ opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 15:2396-2406 (1995).
6. Pei, G., B. L. Kieffer, R. J. Lefkowitz, and J. F. Neil. Agonist-dependent phosphorylation of the mouse δ-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Mol. Pharmacol. 48: 173-177 (1995).
7. Zhang, L., Y. Yu, S. Mackin, F. F. Weight, G. R. Uhl, and J. B. Wang. Differential μ opioid receptor phosphorylation and desensitization induced by agonists and phorbol esters. J. Biol. Chem. 271:11449-11454 (1996).
8. Maldonado, R., J. A. Blendy, E. Tzavara, P. Gass, B. P. Roques, J. Hanoune, and G. Schutz. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science (Washington D. C.) 273:657-659 (1996).
9. Chen, L., Y. Gu, and L.-Y. M. Huang. The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat. J. Physiol. 482:575-581 (1995).
10. Trujillo, K. A., and H. Akil. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science (Washington D. C.) 251:85-87 (1991).
11. Tiseo, P. J., J. Cheng, G. W. Pasternak, and C. E. Inturrisi. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes. J. Pharmacol. Exp. Ther. 268:195-201 (1994).
12. Trujillo, K. A., and H. Akil. Inhibition of opiate tolerance by noncompetitive N-methyl-D-aspartate receptor antagonists. Brain Res. 633: 178-188 (1994).
13. Bhargava, H. N., and S. N. Thorat. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa opioid receptor agonist, in the mouse. Brain Res. 649:111-116 (1994).
14. Wong, C. S., C.-H. Cherng, H.-N. Luk, and S.-T. Ho. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at μ-opioid receptors. Eur. J. Pharmacol. 297:27-33 (1996).
15. Mercadante, S., F. Lodi, M. Sapio, M. Calligara, and R. Serretta. Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain. J. Pain Symptom Manag. 10:564-568 (1995).
16. 3H]MK-801 binding as functional measures. Mol. Brain Res. 22:166-172 (1994).
17. Abdelhamid, E. E., M. Sultana, P. S. Portoghese, and A. E. Takemori. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J. Pharmacol. Exp Ther. 258:299-303 (1991).
18. Hamprecht, B., T. Glaser, G. Reiser, E. Bayer, and F. Propst. Culture and characteristics of hormone-responsive neuroblastoma x glioma hybrid cells. Methods Enzymol. 109:316-341 (1985).
19. McBain, C. J., and M. L. Mayer. N-methyl-D-aspartic acid receptor structure and function. Physiol. Rev. 74:723-760 (1994).
20. MacDermott, A. B., M. L. Mayer, G. L. Westbrook, S. J. Smith, and J. L. Baker. NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurons. Nature (Lond.) 321:519-522 (1986).
21. Nishizuka, Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science (Washington D. C.) 258:607-614 (1992).
22. Ueda, H., T. Miyamae, C. Hayashi, S. Watanabe, N. Fukushima, Y. Sasaki, T. Iwamura, and Y. Misu, Protein kinase C involvement in homologous desensitization of δ-opioid receptor coupled to Gi-phospholipase C activation in Xenopus oocytes. J. Neurosci. 15:7485-7499 (1995).
23. Louie, A. K., E. S. Bass, J. Zhan, P. Y. Law, and H. H. Loh. Attenuation of opioid receptor activity by phorbol esters in neuroblastoma x glioma NG108-15 hybrid cells. J. Pharmacol. Exp. Ther. 253:401-407 (1990).
24. 2+ release or protein kinase C activation significantly reduces the development of morphine dependence. Eur. J. Pharmacol. 300:173-181 (1996).
25. 2+ mobilization in human platelet. Eur. J. Biochem. 205:1003-1009 (1992).
26. Yoshimasa, T., D. R. Sibley, M. Bouvier, R. J. Lefkowitz, and M. G. Caron. Cross-talk between cellular signaling pathways suggested by phorbolester-induced adenylate cyclase phosphorylation. Nature (Lond.) 327: 67-70 (1987).
27. 2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell 67:723-730 (1991).